Clinical significance and management of extra-axillary sentinel lymph nodes: Worthwhile or irrelevant?

Surgical Oncology Clinics of North America

Volumn 19, Issue 3, 2010, Pages 507-517

  Cody, Hiram S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Internal mammary nodes; Lymphoscintigraphy; Mastectomy; Sentinel lymph node

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MASTECTOMY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; AXILLA; BREAST TUMOR; FEMALE; LYMPH NODE; LYMPHADENECTOMY; PATHOLOGY;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY;

EID: 77954173554     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.04.002     Document Type: Review

References (57)

1. Kim T., Giuliano A.E., Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 2006, 106:4-16.
2. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553.
3. Krag D.N., Anderson S.J., Julian T.B., et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007, 8:881-888.
4. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006, 98:599-609.
5. Zavagno G., De Salvo G.L., Scalco G., et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008, 247:207-213.
6. Gill G. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 2009, 16:266-275.
7. Cody H.S., Fey J., Akhurst T., et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001, 8:13-19.
8. McMasters K.M., Tuttle T.M., Carlson D.J., et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000, 18:2560-2566.
9. Stibbe E.P. The internal mammary lymphatic glands. J Anat 1918, 52:258-264.
10. Handley R.S., Thackray A.C. Invasion of the internal mammary lymph glands in carcinoma of the breast. Br J Surg 1947, 1:15-20. (The Bradshaw Lecture).
11. Turner-Warwick R.T. The lymphatics of the breast. Br J Surg 1959, 46:574-582.
12. Haagensen C.D. The lLymphatics of the breast. The lymphatics in cancer 1972, 340-344. WB Saunders, Philadelphia. C.D. Haagensen, C.R. Feind, F.P. Herter (Eds.).
13. Halsted W.S. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Rep 1894, 4:297-350.
14. Wangensteen O.H. Remarks on extension of the Halsted operation for cancer of the breast. Ann Surg 1949, 130:315-316.
15. Wangensteen O.H., Lewis F.J., Athelger S.W. The extended or super-radical operation for carcinoma of the breast. Surg Clin North Am 1956, 36:1051-1063.
16. Urban J.A. Radical excision of the chest wall for mammary cancer. Cancer 1951, 4:1263-1285.
17. Urban J.A. Radical mastectomy in continuity with en bloc resection of internal mammary lymph node chain: new procedure for primary operable cancer of breast. Cancer 1952, 5:992-1008.
18. Veronesi U., Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981, 47:170-175.
19. Veronesi U., Marubini E., Mariani L., et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 1999, 35:1320-1325.
20. Veronesi U., Cascinelli N., Bufalino R. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 1983, 198:681-684.
21. Cody H.S., Urban J.A. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995, 2:32-37.
22. Klauber-DeMore N., Bevilacqua J.B., VanZee K.J., et al. Comprehensive review of the management of internal mammary metastases in breast cancer. J Am Coll Surg 2001, 193:547-555.
23. Fisher B. Laboratory and clinical research in breast cancer: a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res 1980, 40:3863-3874.
24. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106. Early Breast Cancer Trialists' Collaborative Group.
25. Bevilacqua J., Gucciardo G., Cody H.S., et al. Proposed patient selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer. Eur J Surg Oncol 2002, 28:603-614.
26. Chen R.C., Lin N.U., Golshan M., et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management - a systematic review. J Clin Oncol 2008, 26:4981-4989.
27. Fisher B., Redmond C., Fisher E. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985, 312:674-681.
28. Harris E.E., Hwang W.T., Seyednejad F., et al. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Cancer 2003, 98:2144-2151.
29. Nccn. NCCN clinical practice guidelines in oncology: breast cancer v.1. 2010. Available at: Accessed March 1, 2010. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf.
30. Spillane A.J., Noushi F., Cooper R.A., et al. High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer. Ann Oncol 2009, 20:977-984.
31. Linehan D.C., Hill A.D.K., Akhurst T., et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 1999, 6:450-454.
32. Povoski S.P., Olsen J.O., Young D.C., et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol 2006, 13:1412-1421.
33. Tanis P.J., Nieweg O.E., Valdes Olmos R.A., et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001, 192:399-409.
34. Estourgie S.H., Nieweg O.E., Olmos R.A., et al. Lymphatic drainage patterns from the breast. Ann Surg 2004, 239:232-237.
35. Estourgie S.H., Tanis P.J., Nieweg O.E., et al. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 2003, 10:935-941.
36. Farrus B., Vidal-Sicart S., Velasco M., et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys 2004, 60:715-721.
37. Paredes P., Vidal-Sicart S., Zanon G., et al. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging 2005, 32:1283-1287.
38. Leidenius M.H., Krogerus L.A., Toivonen T.S., et al. The clinical value of parasternal sentinel node biopsy in breast cancer. Ann Surg Oncol 2006, 13:321-326.
39. Madsen E., Gobardhan P., Bongers V., et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol 2007, 14:1486-1492.
40. Heuts E.M., Van der Ent F.W.C., von Meyenfeldt M.F., et al. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients. Eur J Surg Oncol 2009, 35:252-257.
41. van der Ploeg I.M., Tanis P.J., Valdes Olmos R.A., et al. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection. Ann Surg Oncol 2008, 15:3239-3243.
42. Port E.R., Fey J., Gemignani M.L., et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 2002, 195:167-172.
43. Port E.R., Garcia-Etienne C.A., Park J., et al. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol 2007, 14:2209-2214.
44. Anderson S.J., Wapnir I., Dignam J.J., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 2009, 27:2466-2473.
45. Wapnir I.L., Anderson S.J., Mamounas E.P., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006, 24:2028-2037.
46. Cody H.S., Borgen P.I. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 1999, 8:85-91.
47. van der Ent F.W., Kengen R.A., van der Pol H.A., et al. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001, 234:79-84.
48. Sacchini G., Borgen P.I., Galimberti V., et al. Surgical approach to internal mammary lymph node biopsy. J Am Coll Surg 2001, 193:709-713.
49. Veronesi U., Arnone P., Veronesi P., et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol 2008, 19:1553-1560.
50. Pugliese M.S., Stempel M.M., Cody H.S., et al. Surgical management of the axilla: do intramammary nodes matter?. Am J Surg 2009, 198:532-537.
51. Intra M., Garcia-Etienne C.A., Renne G., et al. When sentinel lymph node is intramammary. Ann Surg Oncol 2008, 15:1304-1308.
52. Cody H.S., Egeli R.A., Urban J.A. Rotter's node metastases: therapuetic and prognostic considerations in early breast carcinoma. Ann Surg 1984, 199:266-270.
53. Brito R.A., Valero V., Buzdar A.U., et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 2001, 19:628-633.
54. Singletary S.E., Allred C., Ashley P., et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 2003, 83:803-819.
55. Devitt J.E., Michalchuk A.W. Significance of contralateral axillary metastases in carcinoma of the breast. Can J Surg 1969, 12:178-180.
56. Daoud J., Meziou M., Kharrat M., et al. Bull Cancer 1998, 85:713-715. [in French].
57. Huston T.L., Pressman P.I., Moore A., et al. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma. Breast J 2007, 13:158-164.